CAS 1375469-38-7

Formel: C25H30N6O5

InChl: InChI=1S/C25H30N6O5/c1-16-18(4-3-7-26-16)24(33)29-25-28-21-19(23-27-8-9-31(23)25)5-6-20(22(21)34-2)36-15-17(32)14-30-10-12-35-13-11-30/h3-7,17,27,32H,8-15H2,1-2H3/t17-/m1/s1

InChI Key: QJTLLKKDFGPDPF-QGZVFWFLSA-N

SMILES: CC1=C(C=CC=N1)C(=O)N=C2N=C3C(=C4N2CCN4)C=CC(=C3OC)OC[C@@H](CN5CCOCC5)O

(R)-N-(8-(2-Hydroxy-3-morpholinopropoxy)-7-methoxy-2,3-dihydroimidazo[1,2-c]quinazolin-5-yl)-2-methylnicotinamide

CAS: 1375469-38-7

Formel: C₂₅H₃₀N₆O₅

Reinheit: 98%

Farbe und Form: Solid

Molekulargewicht: 494.5429

Ref: IN-DA009IDQ

BAY1082439

CAS: 1375469-38-7

BAY1082439

Reinheit: ≥98%

Molekulargewicht: 494.54g/mol

Ref: 54-BUP02028

BAY1082439

CAS: 1375469-38-7

BAY1082439, an orally bioavailable, selective inhibitor of PI3Kα/β/δ, demonstrates high efficacy in inhibiting the growth of Pten-null prostate cancer [1][2].

Formel: C₂₅H₃₀N₆O₅

Reinheit: 98%

Farbe und Form: White Solid

Molekulargewicht: 494.5429

Ref: TM-T14511

BAY1082439

CAS: 1375469-38-7

(R)-N-(8-(2-Hydroxy-3-morpholinopropoxy)-7-methoxy-2,3-dihydroimidazo[1,2-c]quinazolin-5-yl)-2-methylnicotinamide

Formel: C₂₅H₃₀N₆O₅

Reinheit: 99%

Molekulargewicht: 494.54

Ref: IN-DG755986

(R)-N-(8-(2-Hydroxy-3-morpholinopropoxy)-7-methoxy-2,3-dihydroimidazo[1,2-c]quinazolin-5-yl)-2-methylnicotinamide

CAS: 1375469-38-7

(R)-N-(8-(2-Hydroxy-3-morpholinopropoxy)-7-methoxy-2,3-dihydroimidazo[1,2-c]quinazolin-5-yl)-2-methylnicotinamide is a ligand that binds to the GABA receptor. It is a potent inhibitor of the receptor and has been shown to alter neuronal activity. The inhibition of the GABA receptor by (R)-N-(8-(2-Hydroxy-3-morpholinopropoxy)-7-methoxy-2,3-dihydroimidazo[1,2c]quinazolin--5yl)-2methylnicotinamide may be responsible for its anticonvulsant properties. This compound also inhibits protein interactions with receptors and ion channels.

Formel: C₂₅H₃₀N₆O₅

Reinheit: Min. 95%

Molekulargewicht: 494.5 g/mol

Ref: 3D-AFC46938